Cargando…
非小细胞肺癌新辅助免疫治疗的研究进展、获益人群、治疗周期和疗效预测
The emergence of immune checkpoint inhibitors (ICIs) has dramatically changed the therapeutic outlook for patients with non-small cell lung cancer (NSCLC). Preoperative neoadjuvant immunotherapy has been paid more and more attention as an effective and safe treatment. Neoadjuvant immune therapy, how...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913292/ https://www.ncbi.nlm.nih.gov/pubmed/35224962 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.01 |